Walker, D., Sehested, A., Opocher, E., Jaspan, T., Liu, J., Deasy, R., . . . Grill, J. (2016). LG-62 DEVELOPING RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG) - A CASE-BASED CONSENSUS SURVEY. Neuro Oncol.
Citação norma ChicagoWalker, David, et al. "LG-62 DEVELOPING RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG) - A CASE-BASED CONSENSUS SURVEY." Neuro Oncol 2016.
Citação norma MLAWalker, David, et al. "LG-62 DEVELOPING RISK-BASED SELECTION CRITERIA FOR THE NEXT SIOP TRIAL OF “SIGHT-SAVING THERAPY” FOR CHILDREN WITH NF1-ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG) - A CASE-BASED CONSENSUS SURVEY." Neuro Oncol 2016.